Health ❯ Healthcare ❯ Cancer Research

Biomarkers

PD-L1 Toxicity Management Treatment Efficacy MGMT-unmethylated Glioblastoma Prognostic Biomarkers Patient Data TROP2 Expression Deep Learning HER2 and CD24 Circulating Tumor DNA (ctDNA) Personalized Medicine Lynch Syndrome Circulating Biomarkers Circulating Tumor Cells p53 Protein

AI Pathomics Tool Beats PD-L1 at Predicting Lung Cancer Immunotherapy Benefit

The biology-guided system uses routine pathology slides to give clearer guidance than PD-L1 on who benefits from immunotherapy.

Pediatric Germ Cell Tumors Show Distinct Immune Profiles, Pointing to New Targets

Preclinical Study Highlights HER2 and CD24 as Radiotheranostic Targets in Endometrial Cancer

High-Dose Steroids Undermine Checkpoint Inhibitors in Non-Small Cell Lung Cancer

Capsule Sponge Test Could Replace Endoscopies for Over Half of Barrett’s Oesophagus Patients